Adaptive radiation therapy for prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a special type of radiation therapy for prostate cancer that adjusts to small changes in your body. It aims to better target the cancer while reducing side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 18
- You have prostate cancer confirmed by a biopsy
- Your planned treatment is radiation therapy to the prostate only (not to other areas)
- You are able to get up and take care of yourself (fully active or with some limits)
- You do not have a hip replacement or other artificial hip joint
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special type of radiation called adaptive radiotherapy for people with certain pelvic cancers. Adaptive radiotherapy adjusts the treatment plan each day based on changes in your body, which may help target the cancer more precisely and reduce side effects.
This trial tests a type of radiation that adapts to your body's changes during treatment. It is for men with low- to intermediate-risk prostate cancer that hasn't spread.
This trial tests a more precise form of radiation therapy (adaptive radiotherapy) for people with urological cancers. It aims to adjust the radiation beam in real time to better target the tumor and protect healthy tissues, which may lead to fewer side effects.
This trial tests a type of targeted radiation (SBRT) for prostate cancer that has come back only in certain lymph nodes around the belly or hip. The goal is to see if adapting the radiation plan during treatment can make the response last longer.
This trial tests a new way to deliver high-precision radiation to the prostate using daily MRI or CT scans to adjust the treatment based on your exact anatomy. It aims to make radiation more accurate and reduce side effects.
This trial tests a new way to deliver radiation therapy for prostate cancer using adaptive techniques—meaning the treatment adjusts based on imaging done right before each session. The goal is to safely give higher doses in fewer treatments, reducing your overall therapy time.
Hear when a new Prostatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.